China Universal Asset Management Co., Ltd. Ligand Pharmaceuticals Inc Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 3,514 shares of LGND stock, worth $429,902. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,514
Previous 2,112
66.38%
Holding current value
$429,902
Previous $177,000
98.31%
% of portfolio
0.04%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding LGND
# of Institutions
257Shares Held
18.2MCall Options Held
26.8KPut Options Held
9.3K-
Black Rock Inc. New York, NY2.87MShares$351 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$241 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$123 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3887KShares$109 Million0.1% of portfolio
-
State Street Corp Boston, MA707KShares$86.5 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.07B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...